Clinical Outcome-Related Cancer Pathways and Mutational Signatures in Patients With Unresectable Esophageal Squamous Cell Carcinoma Treated With Chemoradiotherapy

医学 危险系数 放化疗 肿瘤科 内科学 食管癌 癌症研究 置信区间 癌症
作者
Li Li,Jujie Sun,Ning Liu,Ruoying Yu,Junli Zhang,Jiaohui Pang,Qiuxiang Ou,Ying Yin,Jinfeng Cui,Xuling Yao,Ranran Zhao,Yang Washington Shao,Shuanghu Yuan,Jin-Ming Yu
出处
期刊:International Journal of Radiation Oncology Biology Physics [Elsevier BV]
卷期号:115 (2): 382-394 被引量:14
标识
DOI:10.1016/j.ijrobp.2022.07.1835
摘要

Definitive chemoradiotherapy (dCRT) is a standard-of-care for locally advanced unresectable esophageal squamous cell carcinoma (ESCC). However, even in individuals treated with the same dCRT regimen, differences in the local control rate and radiation-induced thoracic toxicity exist (radiation-induced esophagitis [RIE]).Here, we describe a comprehensive genomic evaluation of pretreatment tumor tissue samples from 183 patients with ESCC using targeted sequencing of 474 cancer-related genes. The association between endpoints (progression-free survival [PFS], overall survival, locoregional relapse-free survival, distant metastasis-free survival), toxicity (RIE) and genomic features, including altered pathways and the mutational signature, was analyzed. An independent cohort of 84 stage II-III patients with ESCC was used for validation.Gene alterations in the cell cycle pathway were identified in 87% of cases. Other frequently altered pathways included PI3K-AKT (45.9%), NOTCH (38.3%), NRF2 (36.6%), RKT-RAS (28.4%), and homologous recombination repair (HRR; 20.2%). HRR pathway alterations correlated with shortened PFS (mutation vs wild-type: 9.00 vs 14.40 months, hazard ratio, 2.10; 95% confidence interval, 1.29-3.44), while altered RTK-RAS pathways were correlated with worse overall survival in patients with ESCC treated with chemoradiotherapy (mutation vs wild-type: 23.70 vs 33.50 months; hazard ratio, 1.65; 95% confidence interval, 1.01-2.69). Furthermore, enrichment of apolipoprotein B mRNA editing enzyme, catalytic polypeptide (APOBEC) signatures (signatures 2 and 13) was identified in ESCC tumors with altered HRR pathways. High APOBEC signatures and an altered HRR pathway were correlated with poor prognoses in dCRT-treated ESCC. Moreover, the APOBEC signature and/or the presence of HRR pathway alterations were associated with poor PFS and overall survival, which was validated in an independent whole exome sequence cohort. Notably, the altered HRR pathway was also associated with high-grade RIE toxicity in patients with ESCC.Collectively, our results support the use of comprehensive genomic profiling to guide treatment and minimize RIE in patients with ESCC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
lxn完成签到,获得积分20
刚刚
刚刚
刚刚
linn发布了新的文献求助10
刚刚
ZR完成签到,获得积分10
1秒前
ARIA完成签到,获得积分10
1秒前
ErwinW完成签到,获得积分10
1秒前
老帅比发布了新的文献求助10
1秒前
1秒前
尹天扬完成签到,获得积分10
1秒前
1秒前
fabius0351完成签到 ,获得积分0
1秒前
111发布了新的文献求助10
2秒前
咸鸭蛋完成签到 ,获得积分10
2秒前
今后的应助被霁月采纳,获得10
2秒前
真圆完成签到 ,获得积分10
3秒前
3秒前
yangyang完成签到,获得积分10
4秒前
冷静汉堡发布了新的文献求助10
4秒前
5秒前
优美的剑发布了新的文献求助10
5秒前
5秒前
眯眯眼的冰蓝完成签到 ,获得积分10
5秒前
5秒前
com完成签到,获得积分10
6秒前
寂寞的君浩完成签到 ,获得积分10
6秒前
daidai完成签到,获得积分10
6秒前
阿聪完成签到,获得积分10
6秒前
rice完成签到,获得积分10
7秒前
南川发布了新的文献求助10
7秒前
开心思山完成签到 ,获得积分10
7秒前
8秒前
8秒前
无语的小蘑菇完成签到,获得积分20
8秒前
nbnb完成签到,获得积分10
9秒前
皮皮蛋发布了新的文献求助30
9秒前
9秒前
又困了大王完成签到,获得积分10
9秒前
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180488
求助须知:如何正确求助?哪些是违规求助? 9570485
关于积分的说明 21812623
捐赠科研通 7776592
什么是DOI,文献DOI怎么找? 3433286
关于科研通互助平台的介绍 2557522
邀请新用户注册赠送积分活动 2479162